These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 17554716

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Should fluoroquinolones be first-line antibiotics in the treatment of community-acquired pneumonia in areas with high incidence of tuberculosis?
    Hsueh PR.
    J Microbiol Immunol Infect; 2007 Oct; 40(5):386-7. PubMed ID: 17932596
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fluoroquinolones in the management of community-acquired pneumonia.
    Albertson TE, Dean NC, El Solh AA, Gotfried MH, Kaplan C, Niederman MS.
    Int J Clin Pract; 2010 Feb; 64(3):378-88. PubMed ID: 20456176
    [Abstract] [Full Text] [Related]

  • 6. Role of gemifloxacin in community-acquired pneumonia.
    Tillotson GS.
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):405-18. PubMed ID: 18662107
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Empiric therapy of community-acquired pneumonia: a transatlantic controversy].
    Garin N, Nendaz M.
    Rev Med Suisse; 2006 Jan 25; 2(50):289-90, 292-4. PubMed ID: 16503046
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella pneumophila.
    Nakamura S, Yanagihara K, Izumikawa K, Seki M, Kakeya H, Yamamoto Y, Senjyu H, Saito A, Kohno S.
    J Infect; 2009 Sep 25; 59(3):222-4. PubMed ID: 19592113
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.
    Schriger DL, Hoffman JR, Cooper RJ, Gupta M.
    J Emerg Med; 2007 Aug 25; 33(2):197; discussion 197. PubMed ID: 17692777
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Approaches to treatment of community-acquired pneumonia in the emergency department and the appropriate role of fluoroquinolones.
    Moran G.
    J Emerg Med; 2006 May 25; 30(4):377-87. PubMed ID: 16740445
    [Abstract] [Full Text] [Related]

  • 19. Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study.
    Wang JY, Lee CH, Yu MC, Lee MC, Lee LN, Wang JT.
    Eur Respir J; 2015 Aug 25; 46(2):567-70. PubMed ID: 25900374
    [No Abstract] [Full Text] [Related]

  • 20. Pulmonary tuberculosis presenting as community-acquired pneumonia.
    Asnis DS, Cherian S, Sun T, Shrestha S, Santucci T.
    Clin Infect Dis; 2002 Dec 15; 35(12):1574-5. PubMed ID: 12471584
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.